Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Interest & Investment Income (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Interest & Investment Income data on record, last reported at $107000.0 in Q4 2021.

  • For Q4 2021, Interest & Investment Income rose 50.7% year-over-year to $107000.0; the TTM value through Dec 2021 reached $467000.0, up 224.31%, while the annual FY2025 figure was $14.7 million, 18.79% down from the prior year.
  • Interest & Investment Income reached $107000.0 in Q4 2021 per COGT's latest filing, down from $115000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $408000.0 in Q4 2018 and bottomed at $3000.0 in Q2 2020.
  • Average Interest & Investment Income over 4 years is $126937.5, with a median of $94000.0 recorded in 2018.
  • Peak YoY movement for Interest & Investment Income: crashed 92.35% in 2019, then soared 3900.0% in 2021.
  • A 4-year view of Interest & Investment Income shows it stood at $408000.0 in 2018, then crashed by 85.05% to $61000.0 in 2019, then rose by 16.39% to $71000.0 in 2020, then surged by 50.7% to $107000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $107000.0 in Q4 2021, $115000.0 in Q3 2021, and $120000.0 in Q2 2021.